Background: Toll-like receptor 4 (TLR4) is critical for ethanol (EtOH)-induced liver injury. TLR4 signaling is mediated by 2 proximal adaptor molecules: myeloid differentiation primary response protein (MyD88) and TLR-domain-containing adaptor-inducing interferon-b (TRIF). Studies utilizing global knockouts of MyD88 and TRIF identified a predominant role for TRIF signaling in the progression of EtOH-induced liver injury. In contrast, IL-1 receptor, which signals solely via the MyD88 pathway, is also known to mediate EtOH-induced liver injury. We postulated that a cell-specific role for MyD88 in myeloid cells might explain these apparently discrepant roles of MyD88. Here we made use of myeloid-specific MyD88-deficient (MyD88
A LCOHOL CAUSES A dysbiosis of the gut microflora associated with an increased intestinal permeability, resulting in increased translocation of bacterial products into the circulation Rao et al., 2004) . The interaction of alcohol with bacterial products (peptidoglycan, LPS, flagellin, CpG DNA) and cytokines (such as TNFa, IL-1, and IL-6) alters the metabolism and immune response in the liver and causes liver injury and chronic inflammation, leading to alcoholic liver disease (ALD) Wang et al., 2012) . Among the different Toll-like receptors (TLRs), evidence shows that TLR4 signaling is required for the development and pathogenesis of ALD (Roh and Seki, 2013) . TLR4 has ability to activate 2 distinct pathways: myeloid differentiation primary response gene 88 (MYD88)-dependent and MyD88-independent/TLR-domaincontaining adaptor-inducing interferon-b (TRIF)-dependent pathways (Takeda and Akira, 2015) . The MyD88-dependent pathway is mediated by the adaptors MyD88 and TIRAP, leading to activation of NFjB and MAPK family members and induction of inflammatory cytokines (Takeda and Akira, 2015; Yamamoto et al., 2003) . The MyD88-independent pathway involves the adaptors TRIF and TRAM, leading to activation of IRF3 and induction of type I interferons, as well as NFjB activation (Fitzgerald et al., 2003; Zhao et al., 2008) . Making use of global knockouts for TLR4, MyD88, and TRIF, studies have shown that chronic ethanol (EtOH)-induced liver injury is predominantly mediated via TLR4 and the MyD88-independent TRIF/IRF3-dependent cascade, but not the MyD88 pathway (Uesugi et al., 2001; Zhao et al., 2008) . However, it is important to note that the IL-1 receptor (IL-1R), which exclusively signals through the MyD88 pathway, is also required for the pathogenesis of ALD (Petrasek et al., 2012) . Recent evidence indicates that activation of TLR4 signaling by low concentrations of LPS, similar to those observed in both patients with ALD and murine models of chronic EtOH exposure, results in the formation of a MyD88-IRAKM myddosome, leading to the activation of NFjB and expression of inflammatory genes (Zhou et al., 2016) . Importantly, IRAKM is only expressed in myeloid cells and IRAKM-deficient mice are protected from chronic EtOHinduced liver disease (Zhou et al., 2016) . Thus, from the data available, it remains unclear how the MyD88-dependent pathway participates and contributes to the development and pathogenesis of ALD.
While the activity of MyD88 on immune cells is most well understood, MyD88 is expressed in multiple cell types that can contribute to ALD, including hepatocytes (Duparc et al., 2016) , endothelial cells (Jagavelu et al., 2010) , intestinal epithelial cells (Everard et al., 2014) , as well as cells in the central nervous system (Kleinridders et al., 2009 ). There is accumulating evidence from other models of chronic inflammatory diseases that there are cell-specific functions for MyD88. For example, there is an interaction between MyD88 on endothelial cells and myeloid cells in the development of high-fat diet-induced inflammation and insulin resistance (Yu et al., 2014) . Further, hepatocyte MyD88 contributes to the regulation of bile acids and specific nuclear receptors that regulate glucose and lipid metabolism (Duparc et al., 2016) . Therefore, it is possible that there is a cell typespecific interplay between the contributions of MyD88 in multiple cell types during progression of ALD.
Taken together, these data led us to hypothesize that myeloid-MyD88 may specifically contribute to the progression of chronic EtOH-induced liver injury. Here we have used myeloid-specific MyD88-deficient (MyD88 LysM-KO ) mice to study specific contributions of MyD88 in myeloid cells during progression of EtOH-inducing liver injury. Loss of MyD88 in myeloid cells reduced EtOH-induced increases in plasma alanine aminotransferase (ALT) and hepatic steatosis. EtOH-induced lobular inflammation and expression of pro-inflammatory mediators was also attenuated in livers of MyD88
LysM-KO mice. Loss of MyD88 in myeloid cells also blunted the accumulation of mature IL-1b and cleaved caspase-1, indicating a reduction in activation of the inflammasome. Taken together, these results indicate that myeloid-MyD88 participates in multiple aspects of EtOH-induced liver injury.
MATERIALS AND METHODS

MyD88
fl/fl and LysM-CRE mice were purchased from Jackson Labs (Bar Harbor, ME). A colony of LysM-CRE-MyD88 fl/+ mice was established at the Cleveland Clinic by serial crossing the parental MyD88 fl/fl strain with the LysM-CRE strain. For experiments, the LysM-CRE-MyD88 fl/+ mice were crossed with MyD88 fl/fl to generate MyD88 LysM-KO . Littermate LysM-CRE-MyD88 fl/+ mice were used as controls. Lieber-DeCarli high-fat diet EtOH and control diets were purchased from Dyets (Bethlehem, PA).
Antibodies were from the following sources: CYP2E1 and CD45 (Abcam, Cambridge, MA), 4-hydroxynonenal (Alpha Diagnostics, San Antonio, TX), TNF-a (Fitzgerald Inc., North Acton, MA), F4/ 80 (AbD Serotec, Raleigh, NC), HSC70, and b-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Anti-IL-1b antibody (3ZD) was obtained from the Biological Resources Branch of the NIH. Anti-caspase-1 (p20) antibody was generated as previously described by L. Franchi and G. Nunez (2008) . Antibody against Mincle was from MBL Ltd (Nagoya, Japan). Alexa fluor 488-conjugated secondary antibodies were purchased from Invitrogen (Carlsbad, CA). TUNEL assay kit Apop Tag @ Plus in Situ apoptosis detection kit was purchased from Millipore (Billerica, MA, cat. No. S7111).
Mouse Models
All procedures using animals were approved by the Cleveland Clinic Institutional Animal Care and Use Committee. Female mice were housed in shoe-box cages (2 animals/cage) with microisolator lids. Standard microisolator handling procedures were used throughout the study. Mice were randomized into EtOH-fed and pair-fed groups and then adapted to control liquid diet for 2 days. The EtOH-fed group was then allowed free access to an EtOH-containing diet with increasing concentrations of EtOH: 1% and 2% (vol/vol) each for 2 days, then 4 and 5% EtOH each for 7 days, and finally 6% EtOH for an additional week. The 6% (vol/vol) diet provided EtOH as 32% of total calories in the diet. Control mice were pair-fed diets which iso-calorically substituted maltose dextrins for EtOH over the entire feeding period. At the end of the feeding protocol, mice were anesthetized, blood samples taken into nonheparinized syringes from the posterior vena cava, livers excised, and mice euthanized by exsanguination. Portions of each liver were then either fixed in formalin or frozen in optimal cutting temperature compound (Sakura Finetek U.S.A., Inc., Torrance, CA) for histology, frozen in RNAlater (Qiagen, Valencia, CA) or flash frozen in liquid nitrogen, and stored at À80°C until further analysis. Blood was transferred to EDTA-containing tubes for the isolation of plasma. Plasma was then stored at À80°C.
Histopathology and TUNEL Staining
Formalin-fixed tissues were paraffin-embedded, sectioned, coded, and stained with hematoxylin and eosin. Steatosis and inflammation were scored by our experienced pathologist (X. Liu) on a scale of 0 to 3 on the basis of inflammatory cells infiltrated. Apoptosis was detected using the TUNEL assay and TUNEL-positive cells were colocalized with CD45, as described previously (Smathers et al., 2016) . All images presented in the results are representative of at least 3 images per liver and 4 mice per experimental condition.
Biochemical Assays
Plasma samples were assayed for ALT using a commercially available enzymatic assay kit (Sekisui Diagnostics, Lexington, MA), following the manufacturer's instructions. Total hepatic triglycerides were assayed using the Triglyceride Reagent Kit from Pointe Scientific Inc. (Lincoln Park, MI).
Western Blot Analysis
Frozen liver tissue (0.5-1.0 g) was homogenized in lysis buffer (10 ml/g tissue) and protein concentration was measured using the BCA assay (Pritchard et al., 2007) . Liver lysates were then used for Western blot analysis of cytochrome P450 2E1 (CYP2E1), IL-1b, and caspase-1. HSC 70 or b-actin was used as the loading control.
Isolation of RNA and Quantitative Real-Time Polymerase Chain Reaction
Total RNA was isolated and reverse-transcribed followed by amplification using quantitative real-time polymerase chain reaction (qRT-PCR). The relative amount of target mRNA was determined using the comparative threshold (Ct) method by normalizing target mRNA Ct values to those of 18S.
Statistical Analysis
Values shown in all figures represent the mean AE SEM (n = 4 pair-fed, n = 6 EtOH-fed). Analysis of variance was performed using the general linear models procedure (SAS, Carey, NC). Data were log-transformed as necessary to obtain a normal distribution. Follow-up comparisons were made by least square means testing. pValues of less than 0.05 were considered significant.
Student's t-test was used for comparing values obtained from 2 groups (Fig. 2B,F only) .
RESULTS
Myeloid-MyD88 Contributes to EtOH-Induced Steatosis and Hepatocyte Injury
MyD88
LysM-KO mice and their littermate controls were allowed free access to Lieber-DeCarli EtOH diet for 25 days, with gradually increasing concentrations of EtOH to a final concentration of EtOH as 32% calories during the final week of feeding or pair-fed control diets. Neither body weight, EtOH consumption, nor induction of CYP2E1 was affected by genotype (Table 1) . Hepatic steatosis, visualized with Oil Red O staining (Fig. 1A) or assessed biochemically (Fig. 1B) , was increased in control mice in response to chronic EtOH feeding, but this response was reduced in MyD88
LysM-KO mice. Similarly, chronic EtOH feeding increased plasma ALT, an indicator of hepatocyte injury, in control mice, but not in MyD88
LysM-KO mice (Fig. 1C) .
Deficiency of MyD88 in Myeloid Cells Reduces EtOHInduced Hepatic Inflammation
Chronic EtOH feeding to control mice increased lobular inflammation and steatosis, based on histological scoring (Fig. 1D,E) . These responses were reduced in MyD88
LysM-KO mice (Fig. 1D,E) . Similarly, chronic EtOH feeding increased expression of MCP-1 and IL-1b mRNA in control mice, but not in MyD88
LysM-KO mice ( Fig. 2A) . While chronic EtOH did not increase TNF-a mRNA expression, immunoreactive TNF-a was higher in control mice after EtOH feeding, but not in MyD88
LysM-KO mice ( Fig. 2A,B) . Although Mincle was expressed in livers of EtOH-fed control mice, colocalized with F4/80, Mincle-positive cells were not detected in livers of MyD88
LysM-KO mice (Fig. 2C,D) . In parallel, EtOH-induced phosphorylation of SYK, a downstream target of Mincle, was also attenuated in MyD88
LysM-KO mice (Fig. 2E) . Finally, EtOH-induced accumulation of 4-hydroxynonenal-adducts, a dosimeter of oxidative stress, was also reduced in livers of MyD88
LysM-KO mice (Fig. 2F) .
EtOH-Induced Activation of Caspase-1 and IL-1b are Myeloid-MyD88 Dependent
Chronic EtOH feeding activates the inflammasome pathway, characterized by the presence of mature IL-1b, active caspase-1, and increased expression of NLRP3 and ASC in the liver (Petrasek et al., 2012) . Because of the close association between the TLR4/MyD88 pathway and inflammasome activation in macrophages, here we hypothesized that myeloid-MyD88-mediated hepatocyte injury, in response to EtOH feeding, is mediated through activation of the inflammasome pathway. Indeed, we found that while chronic EtOH feeding increased the cleavage of both IL-1b and caspase-1 in livers of control mice, MyD88
LysM-KO mice were protected from EtOH-induced activation of the inflammasome (Fig. 3) .
Loss of MyD88 in Myeloid Cells Did Not Affect EtOHInduced Apoptosis in Mouse Liver
Chronic EtOH feeding induces programmed cell death pathways including both apoptosis and necroptosis (Roychowdhury et al., 2013; Wu and Cederbaum, 2005) . Hepatocyte apoptosis is associated with the pro-fibrotic effects of EtOH, as phagocytosis of apoptotic hepatocytes activates hepatic stellate cells (Roychowdhury et al., 2012) . In contrast, apoptosis of macrophages is associated with the resolution of inflammatory responses (Tabas, 2010) . Therefore, the consequences of apoptosis to liver homeostasis likely depend on the cell type undergoing apoptotic cell death. Chronic EtOH feeding increased TUNEL + cells in both control and MyD88 LysM-KO mice (Fig. 4A) . Morphologically, the TUNEL + cells resembled both hepatocytes and nonparenchymal cells, consistent with previous reports (Smathers et al., 2016) . TUNELpositive nonparenchymal cells were colocalized with CD45 (Fig. 4B) . The number of TUNEL + /CD45 + double-positive cells in mouse liver following EtOH feeding was not affected by genotype.
DISCUSSION
Chronic EtOH feeding enhances TLR4-dependent signaling in hepatic macrophages via activation of both the MyD88-and TRIF-depending signaling pathways (Mandal et al., 2010) and deletion of TLR4 protects mice from EtOH-induced hepatic injury (Hritz et al., 2008) . Therefore, it was surprising when studies utilizing global knockouts of MyD88 found that MyD88À/À mice were not protected from EtOH-induced liver injury (Hritz et al., 2008) . Interestingly, MyD88 expression in myeloid cells is critical for the development of chronic inflammation in a high-fat dietinduced obesity model (Yu et al., 2014) . This important role for myeloid-MyD88 in hepatic injury in response to high-fat diet (Yu et al., 2014) , coupled with the fact that mice with global MyD88-deficiency are susceptible to bacterial infection, suggested that myeloid-specific deletion of MyD88 would be a useful tool to study the contribution of MyD88 to EtOH-induced liver injury. Therefore, by targeted deletion of MyD88 in myeloid cells using the LysM-CRE system, here we tested the hypothesis that myeloid-MyD88 contributes to chronic EtOH-induced liver injury. Indeed, EtOH-induced steatosis and plasma ALT/AST, markers of hepatocyte injury, were reduced in MyD88
LysM-KO mice compared with controls. In parallel, EtOH-induced hepatic lobular inflammation along with the mRNA expression of the pro-inflammatory mediators including TNF-a, MCP-1, and IL-1b were also ameliorated in MyD88
LysM-KO mice. Increased lobular inflammation and expression of the proinflammatory cytokines/chemokines in mouse liver is characteristic of the progression of chronic EtOH-induced liver injury Wang et al., 2012) . The TLR4-MyD88 pathway is responsible for sensing pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) (Jin et al., 2013) . Mice deficient in TLR4 are resistant to EtOH-induced liver injury (Uesugi et al., 2001) . In response to activation by PAMP/DAMPs, hepatic macrophages increase expression of inflammatory mediators. We have also recently discovered that low concentrations of endotoxin also increase the expression of Mincle, a C-type lectin receptor that acts as a sensor for cell death, on hepatic macrophages (Zhou et al., 2016) . Importantly, chronic EtOH feeding to mice also increased expression of Mincle on hepatic macrophages. Thus, increased expression of Mincle likely contributes to the exacerbation of inflammatory responses during EtOH exposure, providing a link between hepatocyte cell death and inflammatory responses (Zhou et al., 2016) .
Chronic EtOH feeding induces multiple programmed cell death pathways in the liver which includes apoptosis, necroptosis, and pyroptosis. Apoptosis of hepatocytes has been implicated to liver injury while macrophage apoptosis is crucial for resolution of hepatic inflammation.
As loss of myeloid-MyD88 reduced EtOH-induced TNF-a in mouse liver, an inducer of both apoptosis and necroptosis, we hypothesized that myeloid-MyD88 induced hepatocyte injury through activation of TNF-a-induced apoptosis and/ or necroptosis in mouse liver. In contrast, we found that EtOH-induced apoptosis and necroptosis remained unaffected in livers of MyD88
LysM-KO mice, suggesting that myeloid-MyD88 contributes to a different mode of cell death in response to chronic EtOH feeding. Apoptosis can be triggered by multiple pathways in response to EtOH feeding, which include excess reactive oxygen species formation, metabolism-induced hypoxia, Fas ligand activation, or upregulation of the pro-inflammatory mediators such as TNFa (Barnes et al., 2014) . Although loss of MyD88 in myeloid cells was able to reduce EtOH-induced oxidative stress and LysM-KO mice and littermate controls were allowed free access to diets with increasing concentrations of EtOH-or pair-fed control diet. Lysates were prepared from whole liver and analyzed by Western blot analysis for the presence of cleaved IL-1b and cleaved caspase-1 (p20). b-actin was used as a loading control. Band densities were analyzed using ImageJ software and normalized to b-actin. Data represent mean AE SEM. n = 4 to 6. Values with different alphabetical superscripts were significantly different from each other, p < 0.05. n = 4 to 6.
TNF-a, there are still a variety of other pathways that can regulate apoptosis, which are not directly dependent on MyD88. It is therefore not possible to pinpoint one specific pathway contributing to apoptosis in the absence of MyD88. Caspase-1-mediated inflammasome activation is recently implicated to EtOH-induced liver injury. Wild-type mice treated with IL-1R antagonist or mice lacking IL-1R or caspase-1, a central molecule of inflammasome activation, are protected from EtOH-induced liver injury (Petrasek et al., 2012) . Upon activation, caspase-1 cleaves IL-1b, a proinflammatory molecule as well as GSDMD, a key step during the execution phase of pyroptosis (Wallach et al., 2016) . As both DAMPS and PAMPS are linked to induction of pyroptosis and MyD88 is critical for sensing DAMPS/ PAMPS, loss of MyD88 in myeloid cells is expected to reduce EtOH-induced pro-pyroptotic signals in mouse liver. In line of this hypothesis, here we found that EtOH-induced activation of caspase-1, as well as cleavage of IL-1b, was attenuated in livers of MyD88
LysM-KO mice, suggesting that myeloid-MyD88 contributes to EtOH-induced liver injury through induction of pyroptosis.
Taken together, these data indicate that myeloid-MyD88 has no influence on hepatocellular apoptosis or necroptosis. These modes of programmed cell death still occur, likely in response to the direct effects of EtOH metabolism on hepatocytes. However, despite ongoing apoptosis or necroptosis, our data indicate that the absence of MyD88 signaling in myeloid cells interrupts the cycle of EtOH-induced PAMP and DAMP signaling in the liver that eventually leads to exacerbated inflammatory responses during the progression of EtOH-induced liver injury. 
